An investor class action against failed advisory firm Linchpin Capital and its former directors has won its bid to claim its losses against a $10 million insurance policy from AIG.
Over objections from the Law Council, the ACCC has updated its cartel immunity policy to bar lawyers for companies seeking immunity from interviews with applicants for derivative immunity.
An appeals court has rejected Chinese radio manufacturer Hytera’s challenge to a finding it misappropriated the source code of US mobile phone giant Motorola.
A judge has given the green light to a $31.5 million settlement in a class action brought by junior doctors accusing the ACT government and North Canberra Hospital of failing to pay overtime.
Funder LLS has urged the court to approve its 20 per cent cut of a $202 million settlement in a stolen wages class action, saying that reducing the “bottom end” rate could deter investments in public interest class actions.
Mineral Resources and boss Chris Ellison have been hit with a $600,000 suit by a former company lawyer who says she was fired to keep her from making whistleblower disclosures.
Indian drug maker Cipla has lost a challenge to the extension of Novo Nordisk’s patent for Victoza, with a judge rejecting an argument that extensions can be granted only for active ingredients.
The judge hearing ASIC’s case against super fund Cbus has criticised the practice of exchanging concise statements and responses, saying it was a “false economy” of time and cost savings.
A class action on behalf of 700 patients alleging Monash IVF destroyed potentially viable embryos has told a court the majority of late registrants should not share in the $56 million settlement.
The High Court has settled a 16-year battle between the federal government and Sanofi over alleged excess subsidies it paid after a judge blocked the release of a generic version of blood thinner Plavix, saying its job was not to “resurrect” a dead case.